Position in RCUS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$5,463,352
+$5,204,892 QoQ
Shares Held
252,933
+2460.1% QoQ
Ownership
0.201%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ensign Peak Advisors, Inc holds $1,156,213,147 across 116 Biotechnology names. RCUS ranks #47 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
215,165 | $96,079,779 | |
| 2 | INSM |
INSMED Inc
|
499,756 | $81,720,101 | |
| 3 | ABVX |
Abivax S.A.
|
631,838 | $70,355,161 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
836,552 | $62,122,351 | |
| 5 | ARGX |
Argenx SE
|
71,598 | $52,284,439 | |
| 6 | RPRX |
Royalty Pharma plc
|
932,650 | $44,739,220 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
582,318 | $39,673,325 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
717,253 | $35,260,157 |
All Filings in RCUS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,463,352 | 252,933 | Shares | Sole | 2026-05-13 | |
| 2022-09-30 | $258,460 | 9,880 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $250,359 | 9,880 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $311,812 | 9,880 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $399,843 | 9,880 | Shares | Sole | 2022-02-11 | |
| 2020-12-31 | $414,633 | 15,972 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $304,166 | 17,746 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||